Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma. (Q48010246)
Jump to navigation
Jump to search
scientific article published on 2 March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma. |
scientific article published on 2 March 2004 |
Statements
1 reference
Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma. (English)
1 reference
1 reference
Julie M Vose
1 reference
Andres Forero
1 reference
Paul L Weiden
1 reference
Susan J Knox
1 reference
Albert F LoBuglio
1 reference
Jordan Hankins
1 reference
Michael L Goris
1 reference
Vincent J Picozzi
1 reference
Don B Axworthy
1 reference
Hazel B Breitz
1 reference
Robert B Sims
1 reference
Richard G Ghalie
1 reference
Ruby F Meredith
1 reference
2 March 2004
1 reference
1 reference
104
1 reference
227-236
1 reference
1
1 reference
Identifiers
1 reference
1 reference